Yissum revenues rise 18%

Yissum signed 560 new agreements, 46 of which were licenses for using IP and technologies developed at the Hebrew University.

By SHARON WROBEL
March 25, 2009 08:32
hi tech 248.88

hi tech 248.88. (photo credit: Ariel Jerozolimski)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Revenues at Yissum, the research and development company of the Hebrew University, rose 18 percent in 2008 over the previous year marking a third year of double-digit growth. "2008 marks another record year for Yissum. This is the third year in a row that we have shown a double-digit percent increase in revenues," said Yehuda Yarmut, Executive Vice President and Acting CEO of Yissum, the Research & Development Company of the Hebrew University. "Our achievements, are the result of the hard work and dedication of Yissum's professional team, and are especially impressive, in these times of financial turmoil," Yissum generated revenues of $60 million in 2008. The company said that revenues by a total of 76% in the last 3 years. Revenues from royalties and licenses reached about $47m., an increase of 32% compared to 2007. Revenues from research activity generated $12m., an increase of 14% compared to 2007. Last year Yissum signed 560 new agreements, 46 of which were licenses for using IP and technologies developed at the Hebrew University, and 112 were research and lab services agreements funded by the industry. Yissum registered 128 new inventions by Hebrew University researchers over the course of last year.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS